Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Uncertainty: Confidence Intervals

Uncertainty: Confidence Intervals

The confidence interval is the range of values around the mean that contains the true mean. It is expressed as a probability percentage. The interpretation of a 95% confidence interval, for instance, is that the statistician is 95% confident that the true mean falls within the interval. The upper and lower limits of this range are known as confidence limits. The confidence limits for the true mean are estimated from the sample's mean, the standard deviation, and the statistical factor 't,' or...

Propagation of Uncertainty from Systematic Error

Propagation of Uncertainty from Systematic Error

The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this particular...

Propagation of Uncertainty from Random Error

Propagation of Uncertainty from Random Error

An experiment often consists of more than a single step. In this case, measurements at each step give rise to uncertainty. Because the measurements occur in successive steps, the uncertainty in one step necessarily contributes to that in the subsequent step. As we perform statistical analysis on these types of experiments, we must learn to account for the propagation of uncertainty from one step to the next. The propagation of uncertainty depends on the type of arithmetic operation performed on...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Contagious statistical distributions: k-connections and applications in infectious disease environments.

PloS one·2022

Same author

Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea.

Archivos de bronconeumologia·2022

Same author

Telemedicine Strategy to Rescue CPAP Therapy in Sleep Apnea Patients with Low Treatment Adherence: A Pilot Study.

Journal of clinical medicine·2021

Same author

Bayesian Meta-Analysis for Binary Data and Prior Distribution on Models.

International journal of environmental research and public health·2021

Same author

Bayesian Inference in Auditing with Partial Prior Information Using Maximum Entropy Priors.

Entropy (Basel, Switzerland)·2020

Same author

[New guidelines for GACETA SANITARIA. Improving the quality and transfer of scientific knowledge].

Gaceta sanitaria·2020

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.

Miguel A Negrín¹, Francisco-José Vázquez-Polo

¹Department of Quantitative Methods, University of Las Palmas de G.C, 35017 Las Palmas de Gran Canaria, Spain. mnegrin@dmc.ulpgc.es

Journal of Health Economics

|May 21, 2008

Summary

This study introduces Bayesian model averaging to improve cost-effectiveness analysis by accounting for uncertainty in model selection. This method enhances the reliability of comparing treatments, such as antiretroviral therapies for HIV patients.

More Related Videos

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

Area of Science:

Health Economics
Biostatistics
Clinical Trial Analysis

Background:

Linear regression models are increasingly used in cost-effectiveness analysis.
Current methods often overlook uncertainty in selecting predictive covariates for cost and effectiveness.
This oversight can lead to underestimating the uncertainty of key analytical outcomes.

Purpose of the Study:

To address model selection uncertainty in cost-effectiveness analysis.
To propose Bayesian model averaging (BMA) as a robust statistical approach.
To compare the impact of BMA versus traditional methods using clinical trial data.

Main Methods:

Modeling costs and outcomes using patient and Health Centre covariates.
Applying Bayesian model averaging (BMA) to account for model uncertainty.
Utilizing data from a clinical trial comparing two highly active antiretroviral treatments for asymptomatic HIV patients.

Main Results:

BMA provides a more accurate estimation of uncertainty compared to traditional model selection.
The study demonstrates the practical application of BMA in a real-world clinical setting.
Analysis revealed differences in cost and outcomes attributable to patient condition and Health Centre characteristics, beyond treatment effects.

Conclusions:

Bayesian model averaging is a valuable tool for robust cost-effectiveness analysis.
Accounting for model uncertainty is crucial for reliable decision-making in healthcare.
The proposed methods, including cost-effectiveness acceptability curves, aid in interpreting treatment comparisons.